Actively Recruiting
JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
Led by Kasr El Aini Hospital · Updated on 2026-05-01
25
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Androgenetic alopecia is a common form of progressive hair loss. This prospective single-arm pre-post interventional study aims to assess tissue Janus Kinase 2 (JAK2) expression in patients with androgenetic alopecia by comparing balding and non-balding scalp at baseline, and to evaluate changes in JAK2 expression in balding scalp after 3 months of topical minoxidil 5% therapy. Clinical response will be assessed using standardized trichoscopic parameters.
CONDITIONS
Official Title
JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male adults aged 18 to 50 years with androgenetic alopecia
- Mild to moderate disease severity, defined as Hamilton-Norwood scale II to V
- Treatment-naive or willing to have a washout period of at least 1 month from prior hair loss therapies
- Able and willing to provide written informed consent
You will not qualify if you...
- Other types of hair loss, including inflammatory or scarring alopecia
- Inflammatory scalp conditions such as psoriasis or seborrheic dermatitis
- Use of systemic immunosuppressants, JAK inhibitors, or systemic corticosteroids within the last 12 months
- History of severe systemic diseases like kidney, heart, or liver disease
- Chemotherapy in the past 5 years
- Bleeding disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kasr El Aini Hospital
Cairo, Cairo Governorate, Egypt, 11555
Actively Recruiting
Research Team
H
Heba Ahmed
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here